Androgen-responsive POSLUMA-guided Intra-prostatic Boost
Androgen-responsive POSLUMA-guided Intra-prostatic Boost
Recruiting · NCT07393867 · Registry updated 2026-05-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Androgen-responsive POSLUMA-guided Intra-prostatic Boost | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 2 | 2026-05-29 | NCT07393867 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Blue Earth Diagnostics | 26 |
| Dana-Farber/Brigham and Women's Cancer Center | 5 |
| Martin T. King, MD, PhD | 1 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Brigham and Women's Hospital | Boston | United States | 511 |
| Dana Farber Cancer Institute | Boston | United States | 133 |
| Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center | Milford | United States | 4 |
| Dana-Farber/Brigham and Women's Cancer Center in clinical affiliation with South Shore Hospital | Weymouth | United States | 2 |